Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 169.54M P/E - EPS this Y 91.60% Ern Qtrly Grth -
Income -86.51M Forward P/E 12.79 EPS next Y 88.20% 50D Avg Chg 23.00%
Sales 229.74M PEG -0.90 EPS past 5Y - 200D Avg Chg -57.00%
Dividend N/A Price/Book N/A EPS next 5Y 16.90% 52W High Chg -80.00%
Recommedations 2.10 Quick Ratio - Shares Outstanding 189.46M 52W Low Chg 60.00%
Insider Own 0.45% ROA - Shares Float 173.38M Beta 0.89
Inst Own 66.45% ROE - Shares Shorted/Prior 19.87M/19.92M Price 1.79
Gross Margin 52.20% Profit Margin -37.65% Avg. Volume 2,624,620 Target Price 7.41
Oper. Margin 52.47% Earnings Date Jul 30 Volume 7,117,172 Change 5.92%
About Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. The company's products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. The company has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Esperion Therapeutics, Inc. News
05/14/24 Esperion Receives Five Year Patent Extension for Bempedoic Acid, Contained in NEXLETOL® and NEXLIZET®
05/10/24 Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05/08/24 Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues
05/08/24 Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript
05/08/24 Esperion Therapeutics Inc (ESPR) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues ...
05/07/24 Heart Disease Drugmaker Esperion Therapeutics Reports Highest Revenue Yet, Stock Soars
05/07/24 Esperion Therapeutics Inc (ESPR) Surpasses Q1 Revenue Forecasts with a 467% Increase
05/07/24 Esperion Therapeutics (ESPR) Q1 Earnings and Revenues Beat Estimates
05/07/24 Esperion Reports First Quarter 2024 Financial Results
04/29/24 Esperion to Participate in Upcoming May Investor Conferences
04/25/24 These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
04/23/24 Esperion to Report First Quarter 2024 Financial Results on May 7
04/21/24 11 Best Low Price Pharma Stocks To Invest In
04/07/24 Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
04/01/24 Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024
03/28/24 Why Is Esperion Therapeutics (ESPR) Up 2% Since Last Earnings Report?
03/26/24 Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference
03/25/24 Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24
03/22/24 U.S. FDA Approves Broad New Labels for Esperion’s NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
03/22/24 U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
ESPR Chatroom

User Image gbuster57 Posted - 44 minutes ago

$ESPR LOL All of these institutions and their top notch analyst don’t seem to worried about this company only how many shares they can buy in the $2 range

User Image steven1x Posted - 51 minutes ago

$ESPR running low on dilutive warrants ? https://www.esperion.com/node/16461/html#i21637ef2d19f4d809aada9ce74964863_82

User Image YoloAlfred Posted - 1 hour ago

$ESPR

User Image Icebag Posted - 1 hour ago

$ESPR the institutions loaded over 50 million shares last quarter.. what is going on here.

User Image Baruke Posted - 2 hours ago

$ESPR i would make some stick figures and guesstimates, but frankly I think trying to flu0 the volatility moving forward is too risky for an amateur like me. Going to keep digging in to the warrant and options activity, but otherwise just going to sit back, relax, and wait for payday.

User Image BullDonald Posted - 3 hours ago

$ESPR setting up nicely . The way it is setting up, next break out should hold above 3 n up . 🤞🤞🤞

User Image drbob512 Posted - 11 hours ago

$ESPR If the next bounce intraday can hold til the close would be supporting the thesis that ESPR is in a new uptrend, imho.

User Image drbob512 Posted - 11 hours ago

$ESPR remaims constructively positive; stochastics, RSI, Money Flow, but still some selling pressure as seen by the bearish reversal on Friday when ESPR was running so strong very early. Next week could signal that strength can have follow through:

User Image Shmack23 Posted - 14 hours ago

$ESPR Some sales thoughts from my friend: "I got some brand new big name providers in the area to start writing which hopefully will start building an even better base. " "Hit an all-time high this week" "Projected at 84% of my baseline (which was 42% increase)....everyone is behind, but some good things going" (this roughly projects out to a 20% q-o-q increase, but I think that's somewhat misleading, as most payers just NOW coming on...my comment, not theirs). "Had a great lunch at *** *** *** ****, got to see providers that do not talk to reps, and instantly got them to start writing"

User Image YoloAlfred Posted - 22 hours ago

$ESPR Hey don't talk about it...be about it and take a short position.You think it's penny gambling trash.....short it

User Image nutwitskil Posted - 23 hours ago

$ESPR Play with penny stocks and it is a direct path to the poor house. You are better off going to Vegas and betting it all on black on Roulette. Trolls start attacking so I can block you permanently. :)

User Image CliffordCapital Posted - 1 day ago

$ESPR $ADAP $MIST $ASRT we gonna make some serious money on these soon! 💯

User Image TheRedViper Posted - 1 day ago

$ESPR My question is this. Now that the vast majority of warrants have been assumed to be exercised, does this raise the probability of a BO being announced sooner than later? If so, when does everyone think it will happen? I know it could be any day, but maybe how soon?

User Image Chaos24k Posted - 1 day ago

$ESPR My timing is awful. I had 100 $ 3.00 calls expire on this yesterday. I was certain it was going to pop by now. It will probably explode this coming week.

User Image YoloAlfred Posted - 1 day ago

$ESPR My thesis is completed and I'm done pumping.......THE WORST CASE SCENARIO FOR THIS STOCK is in fact a BUYOUT.

User Image BRLondon Posted - 1 day ago

$ESPR I would have signed to finish the Opex day way above $2 so I take it as a very good week. Green light for another leg up now before the next Opex manipulation. With European label, confirmation of the 25M milestone from DSE, and payers coming on board, we should be around $3 by next Opex day. Enjoy the weekend!

User Image doublenickels55 Posted - 1 day ago

$ESPR we keep talking about Sheldon and how horrible he is. Why don't all us shareholders band together and demand his removal? Isn't that what being a shareholder of a company is about - holding accountable those leading it? Let's stop the bitching and use the power of democracy to force him out.

User Image Shmack23 Posted - 1 day ago

$ESPR ….the triple pill answer in the US makes it sound like they are certain of either a) buyout, or b) US partner longer term

User Image coz Posted - 1 day ago

$ESPR https://x.com/RFKracing/status/1791504001126592925

User Image coz Posted - 1 day ago

$ESPR nexlizet car in Sunday's all star race. kesolowski won last week . was rooting for him cuz he hadn't won in 3 years.

User Image GoingNorthTo Posted - 1 day ago

$ESPR good week overall. Good weekend longs. See you Monday

User Image TheRedViper Posted - 1 day ago

$ESPR Geesus, people...this was about opex...get over it. Monday is the start to game being back on. This was not Sheldon. Not that he doesn't deserve some of the blame...OPEX...figure it out.

User Image Lucid__Dreamer Posted - 1 day ago

$ESPR This clown shows up after not posting for a year and barely since 2022. He likes stocks like AAPL, JPM, and DIS. Where does he make his return? Esperion. Ok, pal. And trends are clearly up y/y and q/q whether viewed by DSE sales or Esperion US sales. Incorrect opinions are not superior to facts. Another troll to block.

User Image Lucid__Dreamer Posted - 1 day ago

@nutwitskil You are some tando on the internet who doesnt understand the basic sales trends. I bought nvda in 2015 ahead of their dc expansion and shift from predominantly pc-focused rev base. Do us all a favor and look in the mirror, and then when you find the guy that looks exactly like what you see there, punch him in the face. Enjoy your weekend, clown. $ESPR

User Image Haha1978 Posted - 1 day ago

$ESPR nice. So glad they pulled this back I wasn't done fully loading. Gives people a few more days next week. Thanks Sheldon!!!

User Image Sushiman12345 Posted - 1 day ago

$ESPR fucking ruined my weekend. Thanks Sheldon.

User Image gbola666 Posted - 1 day ago

$ESPR Have you heard the latest news: $ESPR is changing their stock symbol to TBC (Two Buck Chuck). https://tinyurl.com/28k5562a

User Image Baruke Posted - 1 day ago

$ESPR theoretically, that's probably another 1m warrants down, about 1.5m to go before we stop seeing the active suppression.

User Image biokvint Posted - 1 day ago

$ESPR Loaded….

User Image minnesotafarmcountry Posted - 1 day ago

$ESPR Well, after taking the day off to get bids on our new home; I guess I’ll be downsizing a bit after being cautiously optimistic yesterday 😉

Analyst Ratings
HC Wainwright & Co. Buy May 8, 24
Needham Buy May 7, 24
Needham Buy Apr 10, 24
HC Wainwright & Co. Buy Mar 25, 24
Needham Buy Mar 25, 24
HC Wainwright & Co. Buy Feb 28, 24
Needham Buy Feb 27, 24
HC Wainwright & Co. Buy Nov 13, 23
Needham Buy Nov 7, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Warren Eric Chief Commercial Off.. Chief Commercial Officer Sep 20 Sell 1.245 742 924 68,318 09/21/23
Koenig Sheldon L. President and CEO President and CEO May 09 Buy 1.2596 20,000 25,192 312,816 05/10/23
Warren Eric Chief Commercial Off.. Chief Commercial Officer Mar 07 Sell 5.055 5,090 25,730 48,572 03/08/23
Koenig Sheldon L. President and CEO President and CEO Mar 07 Sell 5.056 5,441 27,510 194,815 03/08/23
Foody Joanne M. Chief Medical Office.. Chief Medical Officer Mar 07 Sell 5.065 3,884 19,672 103,060 03/08/23
Warren Eric Chief Commercial Off.. Chief Commercial Officer Aug 31 Buy 7.46 1,000 7,460 54,024 08/31/22
Koenig Sheldon L. President and CEO President and CEO Aug 05 Buy 5.8041 8,606 49,950 198,771 08/08/22
Koenig Sheldon L. President and CEO President and CEO Mar 17 Sell 4.58 571 2,615 194,717 03/18/22